Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Numerate Inc.

www.numerate.com

Latest From Numerate Inc.

Deal Watch: Denali Partners With Sirion To Take On The Blood-Brain Barrier

Denali will collaborate with Sirion in Parkinson’s and Alzheimer’s diseases. Meanwhile, Lundbeck and Elevian unveil drug development partnerships with technology firms at the J.P. Morgan meeting.

Deals Business Strategies

Who's Who In Artificial Intelligence Drug Development

Artificial intelligence companies focused on the life science sector have boomed in the past decade. Many of these firms are working with pharma partners and a small number are pursuing their own drug development pipelines.

Artificial Intelligence Business Strategies

What's Next For Artificial Intelligence In The Clinic?

Numerate CEO Guido Lanza talks to Scrip about how artificial Intelligence, or AI, has been quietly used by some drug developers for the last decade, but its use is now rocketing. Also, what is next for AI in pharma?

Artificial Intelligence Business Strategies

AstraZeneca Signs AI Deal To Pursue Novel Parkinson's Drugs

AstraZeneca is the most recent big pharma to team up with an artificial intelligence business – following in the footsteps of Takeda, Johnson & Johnson, Sanofi and GlaxoSmithKline – having signed a drug discovery deal with Boston-based BERG.

Deals Artificial Intelligence
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
      • Bioinformatics
  • Digital Health
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Numerate Inc.
  • Senior Management
  • Guido Lanza, Pres. & CEO
    John Griffin, PhD, CSO
    Brandon Allgood, PhD, CTO
  • Contact Info
  • Numerate Inc.
    Phone: (650) 472-0632
    1501 Mariposa St.
    Ste. 426
    San Francisco, CA 94107
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register